26 Einträge gefunden

1. Pediatric T-ALL type-1 and type-2 relapses develop along distinct pathways of clonal evolution

   1. Richter-Pechańska, Paulina
   2. Kunz, Joachim B
   3. Rausch, Tobias
   4. Erarslan-Uysal, Büşra
   5. Bornhauser, Beat
   6. Frismantas, Viktoras
   7. Assenov, Yassen

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Characterization of IG-MYC-breakpoints and their application for quantitative minimal disease monitoring in high-risk pediatric Burkitt-lymphoma and -leukemia

   1. Möker, Paula
   2. Zur Stadt, Udo
   3. Zimmermann, Martin
   4. Alawi, Malik
   5. Mueller, Stephanie
   6. Finger, Jasmin
   7. Knörr, Fabian

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Quantification of Minimal Disease by Digital PCR in ALK-Positive Anaplastic Large Cell Lymphoma: A Step towards Risk Stratification in International Trials?

   1. Damm-Welk, Christine
   2. Lovisa, Federica
   3. Contarini, Giorgia
   4. Lüdersen, Jette
   5. Carraro, Elisa
   6. Knörr, Fabian
   7. Förster, Jan

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
4. Integrative genomic analysis of pediatric T- cell lymphoblastic lymphoma reveals candidates of clinical significance

   1. Khanam, Tasneem
   2. Sandmann, Sarah
   3. Seggewiss, Jochen
   4. Ruether, Charlotte Marie
   5. Zimmermann, Martin
   6. Norvil, Allison B
   7. Bartenhagen, Christoph

   2021 - Forschungsinformationssystem des UKE
5. Dose-adjusted EPOCH-rituximab or intensified B-NHL therapy for pediatric primary mediastinal large B-cell lymphoma

   1. Knörr, Fabian
   2. Zimmermann, Martin
   3. Attarbaschi, Andishe
   4. Kabickova, Edita
   5. Maecker-Kolhoff, Britta
   6. Ruf, Stephanie
   7. Kühnle, Ingrid

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
6. Second malignancies after treatment of childhood non-Hodgkin lymphoma: a report of the Berlin-Frankfurt-Muenster study group

   1. Moser, Olga
   2. Zimmermann, Martin
   3. Meyer, Ulrike
   4. Klapper, Wolfram
   5. Oschlies, Ilske
   6. Schrappe, Martin
   7. Attarbaschi, Andishe

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
7. Stem Cell Transplantation and Vinblastine Monotherapy for Relapsed Pediatric Anaplastic Large Cell Lymphoma: Results of the International, Prospective ALCL-Relapse Trial

   1. Knörr, Fabian
   2. Brugières, Laurence
   3. Pillon, Marta
   4. Zimmermann, Martin
   5. Ruf, Stephanie
   6. Attarbaschi, Andishe
   7. Mellgren, Karin

   2020 - Forschungsinformationssystem des UKE
8. Leukemia-induced dysfunctional TIM-3+CD4+ bone marrow T cells increase risk of relapse in pediatric B-precursor ALL patients

   1. Blaeschke, Franziska
   2. Willier, Semjon
   3. Stenger, Dana
   4. Lepenies, Mareike
   5. Horstmann, Martin A
   6. Escherich, Gabriele
   7. Zimmermann, Martin

   2020 - Forschungsinformationssystem des UKE
9. Progressive or relapsed Burkitt lymphoma or leukemia in children and adolescents after BFM-type first-line therapy

   1. Woessmann, Wilhelm
   2. Zimmermann, Martin
   3. Meinhardt, Andrea
   4. Müller, Stephanie
   5. Hauch, Holger
   6. Knörr, Fabian
   7. Oschlies, Ilske

   2020 - Forschungsinformationssystem des UKE
10. Experience with provisional WHO-entities large B-cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group

    1. Au-Yeung, Rex K H
    2. Arias Padilla, Laura
    3. Zimmermann, Martin
    4. Oschlies, Ilske
    5. Siebert, Reiner
    6. Woessmann, Wilhelm
    7. Burkhardt, Birgit

    2020 - Forschungsinformationssystem des UKE
11. Treatment and outcome of IG-MYC+ neoplasms with precursor B-cell phenotype in childhood and adolescence

    1. Herbrueggen, Heidi
    2. Mueller, Stephanie
    3. Rohde, Jonas
    4. Arias Padilla, Laura
    5. Moericke, Anja
    6. Attarbaschi, Andishe
    7. Zimmermann, Martin

    2020 - Forschungsinformationssystem des UKE
12. Quantification of minimal disseminated disease by quantitative PCR and digital PCR for NPM-ALK as prognostic factor in children with anaplastic large cell lymphoma

    1. Damm-Welk, Christine
    2. Kutscher, Nina
    3. Zimmermann, Martin
    4. Attarbaschi, Andishe
    5. Schieferstein, Jutta
    6. Knörr, Fabian
    7. Oschlies, Ilske

    2020 - Forschungsinformationssystem des UKE - frei zugänglich
13. Daunorubicin during delayed intensification decreases the incidence of infectious complications - a randomized comparison in trial CoALL 08-09

    1. Schramm, Franziska
    2. Zimmermann, Martin
    3. Jorch, Norbert
    4. Pekrun, Arnulf
    5. Borkhardt, Arndt
    6. Imschweiler, Thomas
    7. Christiansen, Holger

    2019 - Forschungsinformationssystem des UKE
14. Results of CoALL 07-03 study childhood ALL based on combined risk assessment by in vivo and in vitro pharmacosensitivity

    1. Schramm, Franziska
    2. Zur Stadt, Udo
    3. Zimmermann, Martin
    4. Jorch, Norbert
    5. Pekrun, Arnulf
    6. Borkhardt, Arndt
    7. Imschweiler, Thomas

    2019 - Forschungsinformationssystem des UKE
15. Gemtuzumab Ozogamicin in children with relapsed or refractory acute myeloid leukemia:a report by Berlin-Frankfurt-Münster study group

    1. Niktoreh, Naghmeh
    2. Lerius, Beate
    3. Zimmermann, Martin
    4. Gruhn, Bernd
    5. Escherich, Gabriele
    6. Bourquin, Jean-Pierre
    7. Dworzak, Michael

    2019 - Forschungsinformationssystem des UKE - frei zugänglich
16. PDX models recapitulate the genetic and epigenetic landscape of pediatric T-cell leukemia

    1. Richter-Pechańska, Paulina
    2. Kunz, Joachim B
    3. Bornhauser, Beat
    4. von Knebel Doeberitz, Caroline
    5. Rausch, Tobias
    6. Erarslan-Uysal, Büşra
    7. Assenov, Yassen

    2018 - Forschungsinformationssystem des UKE - frei zugänglich
17. Results and conclusions of the European Intergroup EURO-LB02 trial in children and adolescents with lymphoblastic lymphoma

    1. Landmann, Eva
    2. Burkhardt, Birgit
    3. Zimmermann, Martin
    4. Meyer, Ulrike
    5. Woessmann, Wilhelm
    6. Klapper, Wolfram
    7. Wrobel, Grazyna

    2017 - Forschungsinformationssystem des UKE - frei zugänglich
18. The role of constitutive activation of FMS-related tyrosine kinase-3 andmutational status in infants with-rearranged acute lymphoblastic leukemia

    1. Fedders, Henning
    2. Alsadeq, Ameera
    3. Schmäh, Juliane
    4. Vogiatzi, Fotini
    5. Zimmermann, Martin
    6. Möricke, Anja
    7. Lenk, Lennart

    2017 - Forschungsinformationssystem des UKE - frei zugänglich
19. Acute lymphoblastic leukemia in children with Down Syndrome: a retrospective analysis from the Ponte di Legno study group

    1. Buitenkamp, Trudy D
    2. Izraeli, Shai
    3. Zimmermann, Martin
    4. Forestier, Erik
    5. Heerema, Nyla A
    6. van den Heuvel-Eibrink, Marry M
    7. Pieters, Rob

    2014 - Forschungsinformationssystem des UKE
20. Doxorubicin or daunorubicin given upfront in a therapeutic window are equally effective in children with newly diagnosed acute lymphoblastic leukemia. A randomized comparison in trial CoALL 07-03.

    1. Escherich, Gabriele
    2. Zimmermann, Martin
    3. Janka-Schaub, Gritta

    2013 - Forschungsinformationssystem des UKE